According to the sample size estimation, we included 1291 patients with a PSA test performed in primary health care who were not undergoing follow-up of a previously high PSA and did not have a diagnosis of PCa (study population): 537 cases (42%) registered symptoms suggestive of prostate disease and/or were undergoing BPH treatment. Here, KLK3 is linked to benign prostatic hyperplasia.